Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
LowReport
Cellebrite DI Ltd. (NASDAQ: CLBT) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $10.00 price target on the stock.
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $7.00 to $10.00. They now have a "buy" rating on the stock.
MediumReport
Cellebrite DI Ltd. (NASDAQ: CLBT) had its price target raised by analysts at Needham & Company LLC from $7.00 to $10.00. They now have a "buy" rating on the stock.
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
"Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ blog email newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our blog below: